Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30988% above fair value
$32.16+2.64 (+8.94%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Harrow operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Harrow's operating income for the twelve months ending Jun 30, 2026 was -$2.75M, down 119.1% year over year. For fiscal 2025 it was $30.52M, up 245.9% from the year before. The highest annual figure on record is $30.52M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.52M | +245.9% |
| FY2024 | Dec 31, 2024 | $8.82M | +1946.9% |
| FY2023 | Dec 31, 2023 | $431.00K | -77.5% |
| FY2022 | Dec 31, 2022 | $1.92M | +18.9% |
| FY2021 | Dec 31, 2021 | $1.61M | +319.2% |
| FY2020 | Dec 31, 2020 | $385.00K | – |
| FY2019 | Dec 31, 2019 | -$4.80M | – |
| FY2018 | Dec 31, 2018 | -$5.22M | – |
| FY2017 | Dec 31, 2017 | -$12.16M | – |
| FY2016 | Dec 31, 2016 | -$15.88M | – |
| FY2015 | Dec 31, 2015 | -$14.82M | – |
| FY2014 | Dec 31, 2014 | -$10.15M | – |
| FY2013 | Dec 31, 2013 | -$7.69M | – |
| FY2012 | Dec 31, 2012 | -$4.18M | – |
| FY2011 | Dec 31, 2011 | -$939.23K | – |
| FY2010 | Dec 31, 2010 | -$2.50M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.01M | -196.5% |
| Q1 FY2026 | Mar 31, 2026 | -$22.08M | – |
| Q4 FY2025 | Dec 31, 2025 | $15.59M | +20.9% |
| Q3 FY2025 | Sep 30, 2025 | $14.75M | +1016.4% |
| Q2 FY2025 | Jun 30, 2025 | $11.41M | +645.7% |
| Q1 FY2025 | Mar 31, 2025 | -$11.23M | – |
| Q4 FY2024 | Dec 31, 2024 | $12.90M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.32M | -24.3% |
| Q2 FY2024 | Jun 30, 2024 | $1.53M | -34.9% |
| Q1 FY2024 | Mar 31, 2024 | -$6.93M | -672.6% |
| Q4 FY2023 | Dec 31, 2023 | -$4.88M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.74M | – |
| Q2 FY2023 | Jun 30, 2023 | $2.35M | +39.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.21M | -42.4% |
| Q4 FY2022 | Dec 31, 2022 | -$1.78M | – |
| Q3 FY2022 | Sep 30, 2022 | -$94.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $1.69M | -59.5% |
| Q1 FY2022 | Mar 31, 2022 | $2.10M | -28.0% |
| Q4 FY2021 | Dec 31, 2021 | -$1.76M | -166.8% |
| Q3 FY2021 | Sep 30, 2021 | -$3.72M | -332.7% |
| Q2 FY2021 | Jun 30, 2021 | $4.17M | – |
| Q1 FY2021 | Mar 31, 2021 | $2.92M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.63M | +183.6% |
| Q3 FY2020 | Sep 30, 2020 | $1.60M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.21M | – |
| Q1 FY2020 | Mar 31, 2020 | -$628.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $926.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.40M | – |
| Q2 FY2019 | Jun 30, 2019 | -$767.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$556.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.16M | – |
| Q3 FY2018 | Sep 30, 2018 | -$649.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$624.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.78M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.15M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.76M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.02M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.23M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.51M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.61M | – |
See a number that looks wrong?